
$Stryker(SYK.US) | Leerink ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง๐ฌ ๐๐ฎ๐ญ๐ฉ๐๐ซ๐๐จ๐ซ๐ฆ on ๐๐ญ๐ซ๐ฒ๐ค๐๐ซ, ๐ญ๐ซ๐ข๐ฆ๐ฌ ๐๐ ๐ญ๐จ $๐๐๐
Analyst sees a positive risk/reward skew, believing Stryker remains one of the best-positioned large-cap MedTech names despite minor estimate revisions.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.


